about
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle ...
Read More
65.37
-0.98
(-1.48%)
1.3M
XNAS Volume
XNAS 15 Apr, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Cytokinetics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..